http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
-
Scholar Rock Announces the Addition of Srinivas Akkaraju, M.D., Ph.D. to Its Board of Directors
-
Greenlight Capital Enters ADT (ADT), EchoStar (SATS), Sonos (SONO) - 13F
-
Greenlight's 13F shows new stake in NCR Corp (NCR), increase in Atlas Air (AAWW) and Gold ETF (GLD), maintains Tesla (TSLA) short
-
Carbon, Inc. CEO Named Entrepreneur Of The Year® 2019 National Overall Award Winner
-
Microbiotica Appoints Thomas Lynch as Independent Non-Executive Chairman
-
EY Announces Winners for the Entrepreneur Of The Year® 2019 New Jersey Award
-
Amarin Corp. (AMRN) Reports Alirocumab & Statins Highly Effective in People with Diabetes with Acute Coronary Syndrome
-
Alirocumab and Statins Highly Effective in People with Diabetes with Acute Coronary Syndrome
-
Immunocore Strengthens its Board with Appointments of Laura Wade-Gery and Kristine Peterson as Non-Executive Directors
-
Amarin Corporation plc (Nasdaq: AMRN) to Ring The Nasdaq Stock Market Opening Bell
-
Amarin Corporation CEO, John Thero, to Chair the American Heart Association’s Heart & Stroke Ball in New York City
-
Market Wrap: CPI Slips in Jan.; The 'Net Gets More Neutral; Apple Plans Watch Event
-
Notable Analyst Rating Changes 05/12: (NMBL) (TWTR) (ACT) Upgraded; (AMRN) (DE) (RL) Downgraded
-
Pre-Open Stock Movers 5/12: (TSRO) (PF) (GOGO) Higher; (HSH) (AMRN) (OMC) Lower (more...)
-
Notable Analyst Rating Changes 11/08: (PCLN) (AMRN) (EMN) Upgraded; (WIN) (DE) (NSM) Downgraded
-
Amarin (AMRN) Dips as Another Group DOESN'T Expect NCE
-
Amarin (AMRN) Upside May Be Related to Conference Cancellation
-
Amarin (AMRN) Falls on Patent Delay Chatter
-
Amarin (AMRN) Under Heavy Pressure

